KMID : 1225720140060020156
|
|
Allergy, Asthma & Immunology Research : AAIR 2014 Volume.6 No. 2 p.156 ~ p.162
|
|
Cross-reactivity to Acetaminophen and Celecoxib According to the Type of Nonsteroidal Anti-inflammatory Drug Hypersensitivity
|
|
Kim Yoon-Jeong
Lim Kyung-Hwan Kim Mi-Young Jo Eun-Jung Lee Suh-Young Lee Seung-Eun Yang Min-Suk Song Woo-Jung Kang Hye-Ryun Park Heung-Woo Chang Yoon-Seok Cho Sang-Heon Min Kyung-Up Kim Sae-Hoon
|
|
Abstract
|
|
|
Purpose: Identification of tolerable alternative analgesics is crucial for management in nonsteroidal anti-inflammatory drug (NSAID)-sensitive patients. We investigated cross-reactivity of acetaminophen and celecoxib according to the type of aspirin/NSAID hypersensitivity and aimed to determine the risk factors for cross-intolerance.
Methods: We retrospectively reviewed the medical records of patients intolerant to aspirin and NSAIDs who had undergone an acetaminophen and/or celecoxib oral provocation test. Aspirin/NSAID hypersensitivity was classified into 4 types according to a recently proposed classification: aspirin-exacerbated respiratory disease (AERD), aspirin-exacerbated chronic urticaria (AECU), aspirin-induced acute urticaria/angioedema (AIAU), and NSAID-induced blended reaction (NIRD).
Results: A total of 180 patients with hypersensitivity to aspirin and NSAIDs were enrolled; 149 acetaminophen provocation test results and 145 celecoxib provocation test results were analyzed. The overall cross-reaction rates to acetaminophen and celecoxib were 24.8% and 10.3%, respectively. There was a significant difference in the cross-reactivity to acetaminophen according to the type of NSAID hypersensitivity. Cross-reactivity to acetaminophen was highest in the AECU group (43.9%), followed by the AERD (33.3%), NIBR (16.7%), and AIAU (12.5%) groups. Underlying chronic urticaria was more prevalent in patients with cross-intolerance to both acetaminophen (P=0.001) and celecoxib (P=0.033). Intolerance to acetaminophen was associated with intolerance to celecoxib (P<0.001).
Conclusions: Acetaminophen and celecoxib may induce adverse reactions in a non-negligible portion of aspirin/NSAID-sensitive patients. Physicians should be aware of the possible cross-reactions of these alternative drugs and consider an oral challenge test to confirm their tolerability.
|
|
KEYWORD
|
|
Acetaminophen, celecoxib, cross reactions, hypersensitivity, intolerance, anti-inflammatory agents, non-steroidal
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|